Figure1 (Defencath 1)
Defencath Solution
Product Images NDC 72990-103
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Defencath (NDC 72990-103). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Cormedix Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure2 (Defencath 2)
Figure3 (Defencath 3)
Figure4 (Defencath 4)
DEFENCATH™ Limited is a catheter lock solution containing Taurolidine and Heparin. It is intended for instillation in central venous catheters and is not meant for systemic administration or use as a catheter lock flush. The solution is derived from Porcine Intestinal Mucosa. Each 3 mL vial contains 40.5 mg of Taurolidine (13.5 mg/mL) and 3,000 USP Units of Heparin (1,000 USP Units/mL). It is important to store the solution at a temperature between 20°C to 25°C (68°F to 77°F) and discard any unused portion. The product has a specific lot number (XXXXXX) and expiration date (YYYY-MM-DD).*
Figure3 (Defencath 5)
Figure4 (Defencath 6)
Not available.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
